Yuki Katayama

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

The oncologist

Cancer medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Katayama, Tadaaki Yamada, Ryo Sawada, Hayato Kawachi, Kenji Morimoto, Satoshi Watanabe, Kageaki Watanabe, Takayuki Takeda, Yusuke Chihara, Shinsuke Shiotsu, Makoto Hibino, Taishi Harada, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. The oncologist 29 (5) (2024)
Yuki Katayama, Tadaaki Yamada, Ryo Sawada, Hayato Kawachi, Kenji Morimoto, Satoshi Watanabe, Kageaki Watanabe, Takayuki Takeda, Yusuke Chihara, Shinsuke Shiotsu, Makoto Hibino, Taishi Harada, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. The oncologist 29 (5) (2024)
Yuki Katayama, Tadaaki Yamada, Ryo Sawada, Hayato Kawachi, Kenji Morimoto, Satoshi Watanabe, Kageaki Watanabe, Takayuki Takeda, Yusuke Chihara, Shinsuke Shiotsu, Makoto Hibino, Taishi Harada, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. The oncologist (2024)
Yuki Katayama, Tadaaki Yamada, Ryo Sawada, Hayato Kawachi, Kenji Morimoto, Satoshi Watanabe, Kageaki Watanabe, Takayuki Takeda, Yusuke Chihara, Shinsuke Shiotsu, Makoto Hibino, Taishi Harada, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. The oncologist 29 (5) (2024)
Yuki Katayama, Tadaaki Yamada, Ryo Sawada, Hayato Kawachi, Kenji Morimoto, Satoshi Watanabe, Kageaki Watanabe, Takayuki Takeda, Yusuke Chihara, Shinsuke Shiotsu, Makoto Hibino, Taishi Harada, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. The oncologist 29 (5) (2024)
Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Masaki Ishida, Hayato Kawachi, Yohei Matsui, Ryota Nakamura, Kenji Morimoto, Mano Horinaka, Toshiyuki Sakai, Yoshitaka Sekido, Shinsaku Tokuda, Takayama Koichi
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells. Molecular cancer therapeutics (2023)
Yuki Katayama, Tadaaki Yamada, Shinsaku Tokuda, Naoko Okura, Naoya Nishioka, Kenji Morimoto, Keiko Tanimura, Yoshie Morimoto, Masahiro Iwasaku, Mano Horinaka, Toshiyuki Sakai, Kenji Kita, Seiji Yano, Koichi Takayama
Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells. Cancer medicine 11 (4) (2022)

Yuki Katayama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuki Katayama